Literature DB >> 18033887

Rate control in permanent atrial fibrillation.

Theodora Nikolaidou, Kevin S Channer.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2007        PMID： 18033887      PMCID： PMC2094206          DOI： 10.1136/bmj.39365.511076.BE

Source DB:  PubMed          Journal:  BMJ        ISSN： 0959-8138


× No keyword cloud information.
  46 in total

1.  Effects of antiarrhythmic drugs on variability of ventricular rate and exercise performance in chronic atrial fibrillation complicated with ventricular arrhythmias.

Authors:  M H Hsieh; S A Chen; Z C Wen; C T Tai; C E Chiang; Y A Ding; M S Chang
Journal:  Int J Cardiol       Date:  1998-03-13       Impact factor: 4.164

2.  Effect of betaxolol on the hemodynamic, gas exchange, and cardiac output response to exercise in chronic atrial fibrillation.

Authors:  J E Atwood; J Myers; S Quaglietti; J Grumet; R Gianrossi; T Umman
Journal:  Chest       Date:  1999-04       Impact factor: 9.410

3.  The drug treatment of atrial fibrillation.

Authors:  K S Channer
Journal:  Br J Clin Pharmacol       Date:  1991-09       Impact factor: 4.335

4.  Efficacy and safety of digoxin alone and in combination with low-dose diltiazem or betaxolol to control ventricular rate in chronic atrial fibrillation.

Authors:  K K Koh; K S Kwon; H B Park; S H Baik; S J Park; K H Lee; E J Kim; S H Kim; S K Cho; S S Kim
Journal:  Am J Cardiol       Date:  1995-01-01       Impact factor: 2.778

5.  Comparative study of efficacy and safety of low-dose diltiazem or betaxolol in combination with digoxin to control ventricular rate in chronic atrial fibrillation: randomized crossover study.

Authors:  K K Koh; J H Song; K S Kwon; H B Park; S H Baik; Y S Park; H H In; T H Moon; G S Park; S K Cho
Journal:  Int J Cardiol       Date:  1995-11-24       Impact factor: 4.164

6.  Modulation of ventricular rate in permanent atrial fibrillation: randomized, crossover study of the effects of slow-release formulations of gallopamil, diltiazem, or verapamil.

Authors:  G L Botto; W Bonini; T Broffoni
Journal:  Clin Cardiol       Date:  1998-11       Impact factor: 2.882

7.  Ventricular rate control in chronic atrial fibrillation during daily activity and programmed exercise: a crossover open-label study of five drug regimens.

Authors:  R Farshi; D Kistner; J S Sarma; J A Longmate; B N Singh
Journal:  J Am Coll Cardiol       Date:  1999-02       Impact factor: 24.094

8.  Differential effects of xamoterol and verapamil on ventricular rate regulation in patients with chronic atrial fibrillation.

Authors:  T Lundström; E Moor; L Rydén
Journal:  Am Heart J       Date:  1992-10       Impact factor: 4.749

9.  Comparative effects of the combination of digoxin and dl-sotalol therapy versus digoxin monotherapy for control of ventricular response in chronic atrial fibrillation. dl-Sotalol Atrial Fibrillation Study Group.

Authors:  M Brodsky; R Saini; R Bellinger; R Zoble; R Weiss; L Powers
Journal:  Am Heart J       Date:  1994-03       Impact factor: 4.749

10.  Xamoterol improves the control of chronic atrial fibrillation in elderly patients.

Authors:  P J Lawson-Matthew; K A McLean; M Dent; C A Austin; K S Channer
Journal:  Age Ageing       Date:  1995-07       Impact factor: 10.668
View more
  3 in total

1.  Atrial fibrillation: Rate control and digoxin.

Authors:  Gregory Y H Lip; Michael Rudolf
Journal:  BMJ       Date:  2007-12-08

2.  Pharmacotherapy for atrial fibrillation in elderly hospitalized patients with comorbid congestive heart failure in australia: A retrospective study.

Authors:  Lexin Wang; Shane Curran; Patrick Ball; Fiona White
Journal:  Curr Ther Res Clin Exp       Date:  2008-12

3.  Comparison between ivabradine and low-dose digoxin in the therapy of diastolic heart failure with preserved left ventricular systolic function.

Authors:  Giuseppe Cocco; Paul Jerie
Journal:  Clin Pract       Date:  2013-11-04
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.